HB800
Active Pharmaceutical Ingredient Manufacturing Grant Fund; established.
Status:
In Senate
Latest Action:
Feb. 6, 2026
Senate: Referred to Committee on Finance and Appropriations
Chief Patron:
Luke Torian (D)
Session:
2026 Regular Session
Summary
As Introduced. Active Pharmaceutical Ingredient Manufacturing Grant Fund.
Establishes the Active Pharmaceutical Ingredient Manufacturing Grant Fund to provide grant installment awards between July 1, 2026, and July 1, 2045, in an amount not to exceed $15 million per fiscal year and in an aggregate amount not to exceed $130 million, to a qualified company that (i) engages in ... (More) the manufacture of pharmaceutical substances, (ii) executes a memorandum of understanding with the Commonwealth, and (iii) is expected to make a capital investment of at least $2,148,793,019 and create and maintain at least 468 new full-time jobs. (Less)-
Bill History
- 01/13/2026 - House: Prefiled and ordered printed; Offered 01-14-2026 26102907D
- 01/13/2026 - House: Referred to Committee on Appropriations
- 01/20/2026 - House: Assigned HAPP sub: Commerce Agriculture & Natural Resources
- 01/23/2026 - House: Fiscal Impact Statement from Department of Planning and Budget (HB800)
- 01/27/2026 - House: Placed on Appropriations Agenda
- 01/28/2026 - House: Subcommittee recommends reporting (5-Y 0-N)
- 01/29/2026 - House: Placed on Appropriations Agenda
- 01/30/2026 - House: Reported from Appropriations (20-Y 0-N)
- 02/03/2026 - House: Read first time
- 02/04/2026 - House: Moved from Uncontested Calendar to Regular Calendar
- 02/04/2026 - House: Read second time and engrossed
- 02/05/2026 - House: Read third time and passed House (94-Y 3-N 0-A)
- 02/06/2026 - Senate: Constitutional reading dispensed (on 1st reading)
- 02/06/2026 - Senate: Referred to Committee on Finance and Appropriations
